WTAP knockdown alleviates CD8+ T cell exhaustion and improves anti-PD-1 therapeutic efficacy, demonstrating that WTAP drives hepatocellular carcinoma progression and attenuates antitumor immunity via epitranscriptomic regulation of PD-1 translation (67). Here, CD8A is linked to hepatocellular carcinoma.